FR2838124B1 - Derives de 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino [4,5-b]indole-1-acetamide, leur preparation et leur application en therapeutique - Google Patents
Derives de 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino [4,5-b]indole-1-acetamide, leur preparation et leur application en therapeutiqueInfo
- Publication number
- FR2838124B1 FR2838124B1 FR0204158A FR0204158A FR2838124B1 FR 2838124 B1 FR2838124 B1 FR 2838124B1 FR 0204158 A FR0204158 A FR 0204158A FR 0204158 A FR0204158 A FR 0204158A FR 2838124 B1 FR2838124 B1 FR 2838124B1
- Authority
- FR
- France
- Prior art keywords
- sub
- pyridazino
- indole
- dihydro
- heteroaryl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 230000001225 therapeutic effect Effects 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 3
- 125000005843 halogen group Chemical group 0.000 abstract 2
- 239000002253 acid Substances 0.000 abstract 1
- 150000007513 acids Chemical class 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000001072 heteroaryl group Chemical group 0.000 abstract 1
- 150000004677 hydrates Chemical class 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 125000002183 isoquinolinyl group Chemical group C1(=NC=CC2=CC=CC=C12)* 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 125000002757 morpholinyl group Chemical group 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 125000003386 piperidinyl group Chemical group 0.000 abstract 1
- 125000003373 pyrazinyl group Chemical group 0.000 abstract 1
- 125000002098 pyridazinyl group Chemical group 0.000 abstract 1
- 125000004076 pyridyl group Chemical group 0.000 abstract 1
- 125000000714 pyrimidinyl group Chemical group 0.000 abstract 1
- 125000000719 pyrrolidinyl group Chemical group 0.000 abstract 1
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Dermatology (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Hospice & Palliative Care (AREA)
- Rheumatology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Psychiatry (AREA)
- Obesity (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Indole Compounds (AREA)
Priority Applications (38)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0204158A FR2838124B1 (fr) | 2002-04-03 | 2002-04-03 | Derives de 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino [4,5-b]indole-1-acetamide, leur preparation et leur application en therapeutique |
| UA20041008012A UA77273C2 (en) | 2002-04-03 | 2003-02-04 | 3-heteroaryl-3,5-dihydro-4oxo-4h-pyridazino[4,5-?]indol-1-acetamide derivatives, their production and therapeutic use |
| CA2481460A CA2481460C (en) | 2002-04-03 | 2003-04-02 | 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]indole-1-acetamide derivatives, their preparation and their application in therapeutics |
| HK05108771.3A HK1074632B (en) | 2002-04-03 | 2003-04-02 | 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]indole-1-acetamide derivatives, preparation and use thereof in medicaments |
| KR1020047015629A KR100975999B1 (ko) | 2002-04-03 | 2003-04-02 | 3-헤테로아릴-3,5-디히드로-4-옥소-4H-피리다지노[4,5-b]인돌-1-아세트아미드 유도체, 그의 제조 방법 및의약에서의 그의 용도 |
| JP2003580339A JP4575670B2 (ja) | 2002-04-03 | 2003-04-02 | 3−ヘテロアリール−3,5−ジヒドロ−4−オキソ−4H−ピリダジノ[4,5−b]インドール−1−アセトアミド誘導体、それらの製造、および治療におけるそれらの適用 |
| DE60304327T DE60304327T2 (de) | 2002-04-03 | 2003-04-02 | 3-HETEROARYL-3,5-DIHYDRO-4-OXO-4H-PYRIDAZINOi4,5-BöINDOLACETAMIDDERIVATE, VERFAHREN ZU IHRER HERSTELLUNG UND IHRE THERAPEUTISCHE VERWENDUNG |
| PCT/FR2003/001027 WO2003082874A2 (fr) | 2002-04-03 | 2003-04-02 | DERIVES DE 3-HETEROARYL-3,5-DIHYDRO-4-OXO-4H-PYRIDAZINO[4,5-b]INDOLE-1-ACETAMIDE, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE |
| AT03730299T ATE321763T1 (de) | 2002-04-03 | 2003-04-02 | 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino¬4, - bäindolacetamidderivate, verfahren zu ihrer herstellung und ihre therapeutische verwendung |
| CNB038122227A CN100406459C (zh) | 2002-04-03 | 2003-04-02 | 3-杂芳基-3,5-二氢-4-氧代-4H-哒嗪并[4,5-b]吲哚-1-乙酰胺衍生物,其制备和在治疗中的应用 |
| EP03730299A EP1492792B1 (fr) | 2002-04-03 | 2003-04-02 | Derives de 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino¬4,5-b|indole-1-acetamide,leur preparation et leur application en therapeutique |
| NZ535741A NZ535741A (en) | 2002-04-03 | 2003-04-02 | 3-heteroaryl-3,5-dihydro-4-oxo-4H-pyridazino[4,5-b]indole-1-acetamide derivatives, preparation and use thereof in medicaments |
| AU2003240930A AU2003240930B2 (en) | 2002-04-03 | 2003-04-02 | 3-Heteroaryl-3,5-dihydro-4-oxo-4H-pyridazino[4,5-b]indole-1-acetamide derivatives, preparation and use thereof in medicaments |
| DK03730299T DK1492792T3 (da) | 2002-04-03 | 2003-04-02 | 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]indol-1-acetamidderivater, deres fremstilling og deres terapeutiske anvendelse |
| MXPA04009635A MXPA04009635A (es) | 2002-04-03 | 2003-04-02 | Derivados 3-heteroaril -3, 5-dihidro-4 -oxo-4h -piridacino [4, 5-b] indola-1 -acetamida, preparacion y uso de los mismos en medicamentos. |
| CNB2006101003182A CN100543016C (zh) | 2002-04-03 | 2003-04-02 | 3-杂芳基-3,5-二氢-4-氧代-4H-哒嗪并[4,5-b]吲哚-1-乙酰胺衍生物的中间体化合物 |
| US10/509,695 US7235554B2 (en) | 2002-04-03 | 2003-04-02 | 3-heteroaryl-3,5-dihydro-4-oxo-4H-pyridazino[4,5-b] indole-1-acetamide derivatives, preparation and use thereof in medicaments |
| IL16425703A IL164257A0 (en) | 2002-04-03 | 2003-04-02 | 3-Heteroaryl-3,5-dihydro-4-oxo-4h-pyridazinoÄ4,5-bÜindole-1-acetamide derivatives, preparation and use thereof in medicaments |
| ES03730299T ES2261940T3 (es) | 2002-04-03 | 2003-04-02 | Derivados de 3-hetoeroaril-3,5-dihidro-4-oxo-4hpiridazino-(4,5-b)-indol-1-acetamida, su preparacion y su aplicacion en terapeutica. |
| HRP20040911 HRP20040911B1 (en) | 2002-04-03 | 2003-04-02 | 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]indole-1-acetamide derivatives, preparation and use thereof in medicaments |
| PT03730299T PT1492792E (pt) | 2002-04-03 | 2003-04-02 | Derivados de 3-heteroaril-3,5-di-hidro-4-oxo-4h-piridazino(4, 5-b) ao em terapeutica. |
| SI200330306T SI1492792T1 (sl) | 2002-04-03 | 2003-04-02 | Derivati 3-heteroaril-3,5-dihidro-4-okso-4H-piridazino(4,5-b)indol-1-acetamida, njihova priprava innjihova terapevtska uporaba |
| MEP-237/08A MEP23708A (en) | 2002-04-03 | 2003-04-02 | 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]indole-1-acetamide derivatives, preparation and use thereof in medicaments |
| EA200401146A EA007219B1 (ru) | 2002-04-03 | 2003-04-02 | ПРОИЗВОДНЫЕ 3-ГЕТЕРОАРИЛ-3,5-ДИГИДРО-4-ОКСО-4Н-ПИРИДАЗИНО[4,5-b]ИНДОЛ-1-АЦЕТАМИДА, ИХ ПОЛУЧЕНИЕ И ПРИМЕНЕНИЕ В КАЧЕСТВЕ ЛЕКАРСТВ |
| PL03372617A PL372617A1 (en) | 2002-04-03 | 2003-04-02 | 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino 4,5-b]indole-1-acetamide derivatives, preparation and use thereof in medicaments |
| MEP-2008-237A ME00081B (me) | 2002-04-03 | 2003-04-02 | Derivati 3-heteroaril-3,5-dihidro-4-okso-4h-piridazino (4,5-b)- indol-1-acetamida, njihovo dobijanje i primjena u terapiji |
| BR0309018-3A BR0309018A (pt) | 2002-04-03 | 2003-04-02 | Derivados de 3-heteroaril-3,5-dihidro-4-oxo-4h-piridazino[4,5-b]ind ol-1-acetamida, sua preparação e sua aplicação em terapêutica |
| YUP-869/04A RS51244B (sr) | 2002-04-03 | 2003-04-02 | Derivati 3-heteroaril-3,5-dihidro-4-okso-4h-piridazino(4,5- b)-indol-1-acetamida, njihovo dobijanje i primena u terapiji |
| IL164257A IL164257A (en) | 2002-04-03 | 2004-09-23 | 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]indole-1- acetamide derivatives, their preparation and use thereof in medicaments |
| IS7478A IS2483B (is) | 2002-04-03 | 2004-09-30 | 3-Heteróarýl-3,5-díhýdró-4-oxó-4H-pýridasínó[4,5-b]indól-1-asetamíð afleiður, framleiðsla og notkunþeirra í lyfjum |
| NO20044153A NO329426B1 (no) | 2002-04-03 | 2004-09-30 | 3-heteroaryl-3,5-dihydro-4-okso-4H-pyridazino[4,5-b]indol-1-acetamid-derivater, farmasoytiske preparater omfattende slike, fremgangsmater for fremstilling derav og syntese-mellomprodukter derav |
| ZA2004/07945A ZA200407945B (en) | 2002-04-03 | 2004-10-01 | 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]indole-1-acetamide derivatives preparation and use thereof in medicaments |
| HK07108859.6A HK1102371B (en) | 2002-04-03 | 2005-10-04 | Intermediate compound of 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]indole-1-acetamide derivatives |
| CY20061100885T CY1104998T1 (el) | 2002-04-03 | 2006-06-29 | Εκδοχα 3-ετεροαρυλο-3,5-διϋδρο-4-οξο-4η-πυριδαζινο [4,5-b] ινδολο-1-ακεταμιδιου, η διαδικασια παρασκευης τους kai h εφαρμογη τους στην θεραπευτικη |
| US11/749,342 US7323467B2 (en) | 2002-04-03 | 2007-05-16 | 3-heteroaryl-3,5-dihydro-4-oxo-4H-pyridazino[4,5-b]indole-1-acetamide derivatives, their preparation and their application in therapeutics |
| US11/867,366 US7405306B2 (en) | 2002-04-03 | 2007-10-04 | 3-Heteroaryl-3,5-dihydro-4-oxo-4H-pyridazino[4,5-b]indole-1-acetamide derivatives, their preparation and their application in therapeutics |
| US12/143,059 US20080255129A1 (en) | 2002-04-03 | 2008-06-20 | 3-Heteroaryl-3,5-dihydro-4-oxo-4H-pyridazino[4,5-b]indole-1-acetamide derivatives, their preparation and their application in therapeutics |
| JP2010141683A JP5277208B2 (ja) | 2002-04-03 | 2010-06-22 | 3−ヘテロアリール−3,5−ジヒドロ−4−オキソ−4H−ピリダジノ[4,5−b]インドール−1−アセトアミド誘導体、それらの製造、および治療におけるそれらの適用 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0204158A FR2838124B1 (fr) | 2002-04-03 | 2002-04-03 | Derives de 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino [4,5-b]indole-1-acetamide, leur preparation et leur application en therapeutique |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR2838124A1 FR2838124A1 (fr) | 2003-10-10 |
| FR2838124B1 true FR2838124B1 (fr) | 2004-05-28 |
Family
ID=28052083
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR0204158A Expired - Fee Related FR2838124B1 (fr) | 2002-04-03 | 2002-04-03 | Derives de 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino [4,5-b]indole-1-acetamide, leur preparation et leur application en therapeutique |
Country Status (28)
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006017932A1 (en) * | 2004-08-18 | 2006-02-23 | Genesense Technologies Inc. | Small interfering rna molecules against ribonucleotide reductase and uses thereof |
| JP2009504752A (ja) * | 2005-08-19 | 2009-02-05 | シェーリング コーポレイション | 治療剤としての縮合三環式mGluR1アンタゴニスト |
| US20120041211A1 (en) * | 2009-01-30 | 2012-02-16 | Sythana Suresh Kumar | Novel process for preparing carboxy-containing pyrazoleamido compounds 597 |
| CN105330665B (zh) * | 2015-11-04 | 2017-10-03 | 衡阳师范学院 | 一种抑制激肽释放酶klk7的化合物、制备方法和用途 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2754262B1 (fr) * | 1996-10-08 | 1998-10-30 | Synthelabo | Derives de 1h-pyrido[3,4-b]indole-4-carboxamide, leur preparation et leur application en therapeutique |
| FR2766823B1 (fr) * | 1997-07-30 | 1999-10-08 | Synthelabo | Derives de 4-oxo-3,5-dihydro-4h-pyridazino[4,5-b] indole-1-acetamide, leur preparation et leur application en therapeutique |
| FR2788696B1 (fr) * | 1999-01-26 | 2004-03-05 | Synthelabo | Utilisation de derives de pyridazino [4,5-b] indole-1-acetamide pour la preparation de medicaments destines aux maladies du systeme nerveux central |
| FR2788776B1 (fr) * | 1999-01-26 | 2001-02-23 | Synthelabo | Derives de 4-oxo-3, 5-dihydro-4h-pyridazino [4,5-b] indole-1 -carboxamide, leur preparation et leur application en therapeutique |
| FR2811897A1 (fr) * | 2000-07-24 | 2002-01-25 | Sanofi Synthelabo | UTILISATION DE DERIVES DE PYRIDAZINO[4,5-b]INDOLE-1- ACETAMIDE POUR LA PREPARATION DE MEDICAMENTS DESTINES AU TRAITEMENT DES DYSFONCTIONNEMENTS DES RECEPTEURS DE TYPE PERIPHERIQUE AUX BENZODIAZEPINES |
| FR2811990A1 (fr) * | 2000-07-24 | 2002-01-25 | Sanofi Synthelabo | DERIVES DE 1-(4-OXO-3,5-DIHYDRO-4H-PYRIDAZINO[4,5-b]INDOLE-1 -CARBONYL)PIPERAZINE, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE |
| FR2833953B1 (fr) * | 2001-12-21 | 2004-12-03 | Sanofi Synthelabo | DERIVES DE 3-HETEROARYL-3,5-DIHYDRO-4-OXO-4H-PYRIDAZINO [4,5-b]INDOLE-1-CARBOXAMIDE, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE |
-
2002
- 2002-04-03 FR FR0204158A patent/FR2838124B1/fr not_active Expired - Fee Related
-
2003
- 2003-02-04 UA UA20041008012A patent/UA77273C2/uk unknown
- 2003-04-02 HR HRP20040911 patent/HRP20040911B1/xx not_active IP Right Cessation
- 2003-04-02 CA CA2481460A patent/CA2481460C/en not_active Expired - Fee Related
- 2003-04-02 PL PL03372617A patent/PL372617A1/xx unknown
- 2003-04-02 ES ES03730299T patent/ES2261940T3/es not_active Expired - Lifetime
- 2003-04-02 PT PT03730299T patent/PT1492792E/pt unknown
- 2003-04-02 IL IL16425703A patent/IL164257A0/xx unknown
- 2003-04-02 KR KR1020047015629A patent/KR100975999B1/ko not_active Expired - Fee Related
- 2003-04-02 US US10/509,695 patent/US7235554B2/en not_active Expired - Lifetime
- 2003-04-02 BR BR0309018-3A patent/BR0309018A/pt not_active IP Right Cessation
- 2003-04-02 AU AU2003240930A patent/AU2003240930B2/en not_active Ceased
- 2003-04-02 RS YUP-869/04A patent/RS51244B/sr unknown
- 2003-04-02 AT AT03730299T patent/ATE321763T1/de active
- 2003-04-02 WO PCT/FR2003/001027 patent/WO2003082874A2/fr not_active Ceased
- 2003-04-02 ME MEP-237/08A patent/MEP23708A/xx unknown
- 2003-04-02 EA EA200401146A patent/EA007219B1/ru not_active IP Right Cessation
- 2003-04-02 DE DE60304327T patent/DE60304327T2/de not_active Expired - Lifetime
- 2003-04-02 JP JP2003580339A patent/JP4575670B2/ja not_active Expired - Fee Related
- 2003-04-02 NZ NZ535741A patent/NZ535741A/en not_active IP Right Cessation
- 2003-04-02 MX MXPA04009635A patent/MXPA04009635A/es active IP Right Grant
- 2003-04-02 CN CNB038122227A patent/CN100406459C/zh not_active Expired - Fee Related
- 2003-04-02 DK DK03730299T patent/DK1492792T3/da active
- 2003-04-02 ME MEP-2008-237A patent/ME00081B/me unknown
- 2003-04-02 EP EP03730299A patent/EP1492792B1/fr not_active Expired - Lifetime
- 2003-04-02 CN CNB2006101003182A patent/CN100543016C/zh not_active Expired - Fee Related
-
2004
- 2004-09-23 IL IL164257A patent/IL164257A/en not_active IP Right Cessation
- 2004-09-30 NO NO20044153A patent/NO329426B1/no not_active IP Right Cessation
- 2004-09-30 IS IS7478A patent/IS2483B/is unknown
- 2004-10-01 ZA ZA2004/07945A patent/ZA200407945B/en unknown
-
2006
- 2006-06-29 CY CY20061100885T patent/CY1104998T1/el unknown
-
2007
- 2007-05-16 US US11/749,342 patent/US7323467B2/en not_active Expired - Lifetime
- 2007-10-04 US US11/867,366 patent/US7405306B2/en not_active Expired - Fee Related
-
2008
- 2008-06-20 US US12/143,059 patent/US20080255129A1/en not_active Abandoned
-
2010
- 2010-06-22 JP JP2010141683A patent/JP5277208B2/ja not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20020712B1 (hr) | Farmaceutske strukture koje sadrže derivate azetidina, novi derivati azetidina i njihovo pripremanje | |
| RU2376287C2 (ru) | Производные бензамида, способ их получения и их применение, фармацевтическая композиция и способ обеспечения ингибирующего действия по отношению к hdac | |
| WO2003024967A3 (en) | Indolizines as kinase protein inhibitors | |
| MXPA03010961A (es) | Compuestos de tiazol utiles como inhibidores de proteinas cinasas. | |
| IL152848A0 (en) | 1,2-dihydropyridine derivatives, pharmaceutical compositions containing the same and methods for the production thereof | |
| UA26401C2 (uk) | Заміщеhі 3-аміhохіhуклідиhи | |
| ATE316083T1 (de) | Adamantanderivate | |
| ATE296826T1 (de) | Pyrazolo(1,5)pyridinderivate | |
| DE69023321D1 (de) | Antipicornaviral-Pyridazinamine. | |
| NZ515407A (en) | 4-Phenyl-pyrimidine derivatives | |
| TW200607808A (en) | Pyrido-pyrimidine derivatives, preparation thereof and application thereof | |
| YU49902A (sh) | Supstituisani derivati piperazina kao mtp inhibitori | |
| CY1106029T1 (el) | Παραγωγα 3-ετepοαρυλιο-3,5-διυδρο-4-οξο-4η-πυριδαζινο[4,5-β]ινδολη-1-καρβοξαμιδο, η παρασκευη τους και η εφαρμογη τους στη θepαπευτικη | |
| NO20044153L (no) | 3-heteroaryl-3,5-dihydro-4-okso-4H-pyridazino[4,5-b]indol-1-acetamid-derivater, fremstilling og anvendelse derav i medikamenter | |
| NO20022123L (no) | Osoksazolderivater for anvendelse som inhibitorer for fosfodiesterase VII | |
| WO2005095399A3 (fr) | Derives pyrrolo (2,3-b) pyridine, leur preparation et leur utilisation pharmaceutique comme inhibiteurs de kinases | |
| MEP24408A (en) | Derivatives of 5-(pyridin-3-yl)-1-azabicyclo[3.2.1]octane, the preparation thereof and the application of same in therapeutics | |
| YU16196A (sh) | Upotreba novih benzohinolin-3-ona i njihovih farmaceutski prihvatljivih soli za proizvodnju leka | |
| HK1042288A1 (zh) | 6-[[(芳基和雜芳基)氧]甲基]-萘基-2-甲亞胺酸酰胺衍生物,其製備方法及其在治療方面的應用 | |
| ATE500241T1 (de) | Phenyl- und pyridyl-piperidine mit tnf-wirkung | |
| GR1001123B (el) | Μεθοδος παρασκευης 1,4-διυδροπυριδινων. | |
| CO5631444A2 (es) | Derivados 3-heteroaril-3,5-dihidro-4-oxo-4h-piridazino [4,5- b] indol-1-ecetamida | |
| UY25942A1 (es) | Derivados de 7h-pirrolo (2,3-d)pirimidina, para compuestos intermedios, formulaciones farmacéuticas que los contienen y uso |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| CD | Change of name or company name | ||
| ST | Notification of lapse |
Effective date: 20141231 |